Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Trust & governance

Source and Citation Policy

Which sources we cite, in what order, and their limits.

Our source policy ranks FDA, PubMed, ClinicalTrials.gov, and state boards above first-party provider captures and archives, with secondary reporting used only for context. Each cited fact identifies its source and capture date, and unverifiable claims are excluded rather than softened.

Source order

Official agencies and peer-reviewed literature first; then FDA labeling; then first-party provider and pharmacy records; then archived captures; then reputable secondary reporting for context.

Secondary-source limits

Secondary reporting can provide context but never establishes a price, a pharmacy license, or a clinical outcome on its own; those require first-party or official confirmation.

Frequently asked questions

Do you cite marketing pages?

Only as first-party provider evidence for what a provider claims about itself, clearly labeled as provider-reported — never as proof of a clinical outcome.

Publisher: Microdose GLP One. Compounded medications are not FDA approved. Questions or corrections: see the corrections policy and contact page.